首页> 外文期刊>European Heart Journal - Case Reports >Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis
【24h】

Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis

机译:Covid-19患者中的急性肺栓塞:用纤维蛋白溶解成功处理自由浮动右心血栓的病例报告

获取原文
           

摘要

Background Despite the fast-growing understanding of the coronavirus disease 2019 (COVID-19), patient management remains largely empirical or based on retrospective studies. In this complex scenario, an important clinical issue appears to be represented by the high prevalence of thromboembolic events, but the data regarding high-risk pulmonary embolism (PE) is still not available. Case summary A patient with COVID-19 developed sudden shortness of breath and hypoxia. Early echocardiographic diagnosis of high-risk PE related to right heart thrombus was performed. Systemic thrombolysis was administered with excellent clinical and haemodynamic response. Discussion Pulmonary thromboembolism is a common occurrence in severe COVID-19 infection. In our experience, systemic thrombolysis proved to be effective and for this reason may be considered for life-threatening PE in COVID-19 patients.
机译:背景技术尽管对2019年冠状病毒疾病(Covid-19)的了解,但患者管理仍然主要经验或基于回顾性研究。 在这种复杂的情景中,重要的临床问题似乎是由血栓栓塞事件的高患病率表示的,但是关于高风险肺栓塞(PE)的数据仍然不可用。 病例概述了Covid-19的患者发育了突然的呼吸急促和缺氧。 进行了与右心血栓相关的高风险PE的早期超声心动图诊断。 通过优异的临床和血液动力学反应施用全身溶栓。 讨论肺血栓栓塞是严重的Covid-19感染中的常见发生。 在我们的经验中,系统性溶栓被证明是有效的,因此可以考虑Covid-19患者的生命危及生命的PE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号